Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | intestinal type alkaline phosphatase 1 | 0.3056 | 1 | 0.5 |
Schistosoma mansoni | alkaline phosphatase | 0.3056 | 1 | 1 |
Schistosoma mansoni | alkaline phosphatase | 0.3056 | 1 | 1 |
Toxoplasma gondii | 5'-nucleotidase, C-terminal domain-containing protein | 0.2775 | 0.8539 | 1 |
Treponema pallidum | 5'-nucleotidase (ushA) | 0.2775 | 0.8539 | 0.5 |
Echinococcus granulosus | alkaline phosphatase intestinal gene 2 | 0.3056 | 1 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.1134 | 0 | 0.5 |
Echinococcus granulosus | intestinal type alkaline phosphatase 1 | 0.3056 | 1 | 0.5 |
Echinococcus multilocularis | alkaline phosphatase, intestinal, gene 2 | 0.3056 | 1 | 0.5 |
Schistosoma mansoni | 23-cyclic-nucleotide 2-phosphodiesterase | 0.2767 | 0.8498 | 0.8034 |
Schistosoma mansoni | 23-cyclic-nucleotide 2-phosphodiesterase | 0.2775 | 0.8539 | 0.8088 |
Echinococcus multilocularis | intestinal type alkaline phosphatase | 0.3056 | 1 | 0.5 |
Echinococcus multilocularis | alkaline phosphatase | 0.3056 | 1 | 0.5 |
Echinococcus granulosus | alkaline phosphatase | 0.3056 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IZ (functional) | < 10 mm | Antibacterial activity against Escherichia coli MTCC 443 assessed as zone of inhibition at 100 ug/ml after 14 hrs by cup plate method | ChEMBL. | 23611733 |
IZ (functional) | = 15 mm | Antifungal activity against Candida albicans MTCC 227 assessed as zone of inhibition at 100 ug/ml after 30 hrs by cup plate method | ChEMBL. | 23611733 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.